RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas

Siddhartha Deb(Indian Institute of Technology Madras), Stephen B. Fox(Peter MacCallum Cancer Centre)

British Journal of Cancer

February 18, 2014

10.1038/bjc.2014.31

Cited by 64

Related Papers

<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group

|Journal of Clinical Oncology|2012|1.2k

The 2019 World Health Organization classification of tumours of the breast

|Histopathology|2020|1.1k

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

|Advances in Anatomic Pathology|2017|795

Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial

|Journal of Clinical Oncology|2010|741

No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas

|Nature Genetics|2008|280